The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Autor: G. Cavaletti, D.R. Cornblath, I.S.J. Merkies, T.J. Postma, E. Rossi, B. Frigeni, P. Alberti, J. Bruna, R. Velasco, A.A. Argyriou, H.P. Kalofonos, D. Psimaras, D. Ricard, A. Pace, E. Galiè, C. Briani, C. Dalla Torre, C.G. Faber, R.I. Lalisang, W. Boogerd, D. Brandsma, S. Koeppen, J. Hense, D. Storey, S. Kerrigan, A. Schenone, S. Fabbri, M.G. Valsecchi, A. Mazzeo, A. Pessino, A. Toscano, B. Brouwer, B. Piras, C. Dominguez Gonzalez, C. Tomasello, D. Binda, D. Cortinovis, E. Lindeck Pozza, E.K. Vanhoutte, F. Lanzani, F. Pastorelli, G. Altavilla, G. Granata, I. Ghignotti, J.J. Heimans, L. Mattavelli, L. Padua, L. Reni, M. Bakkers, M. Boogerd, M. Campagnolo, M. Cazzaniga, M. Eurelings, M. Leandri, M. Lucchetta, M. Penas Prado, M. Russo, M.L. Piatti, P. Bidoli, R. Grant, R. Plasmati, R.J. Meijer, S.G. Dorsey, S. Galimberti, W. Grisold

Publikováno v: Annals of Oncology, 24(2), 454-462. Oxford University Press
Annals of Oncology, 24(2), 454-462. Elsevier Ltd.
Cavaletti, G, Cornblath, D R, Merkies, I S J, Postma, T J, Rossi, E, Frigeni, B, Alberti, P, Bruna, J, Velasco, R, Argyriou, A A, Kalofonos, H P, Psimaras, D, Ricard, D, Pace, A, Galie, E, Briani, C, la Torre, C, Faber, C G, Lalisang, R I, Boogerd, W, Brandsma, D, Koeppen, S, Hense, J, Storey, D, Kerrigan, S, Schenone, A, Fabbri, S & Valsecchi, M G 2013, ' The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings ', Annals of Oncology, vol. 24, no. 2, pp. 454-462 . https://doi.org/10.1093/annonc/mds329

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting complication of cancer treatment. Thus far, the impact of CIPN has not been studied in a systematic clinimetric manner. The objective of the study was to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cedae0406e59f84a8143344bc4be68f2
https://doi.org/10.1093/annonc/mds329

ChemInform Abstract: X-RAY CHARACTERIZATION OF SR3SIAL10O20 AND BA3SIAL10O20 AND LUMINESCENCE PROPERTIES ON ACTIVATION WITH CERIUM(3+)

Autor: Johannus Godefridus Verlijsdonk, G. M. Boogerd, Willem Leendert Konijnendijk, W. H. M. M. Van De Spijker

Publikováno v: Chemischer Informationsdienst. 11

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::164a124e58f8df53fd233de0e534f079
https://doi.org/10.1002/chin.198016009

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

Autor: Cavaletti G; Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, Monza, Italy. Electronic address: guido.cavaletti@unimib.it., Cornblath DR; Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA., Merkies ISJ; Department of Neurology, Spaarne Hospital, Hoofddorp/Maastricht, University Medical Center, Maastricht., Postma TJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands., Rossi E; Center of Biostatistics for Clinical Epidemiology, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy., Frigeni B; Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, Monza, Italy., Alberti P; Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, Monza, Italy., Bruna J; Unit of Neuro-Oncology, Department of Neurology, University Hospital of Bellvitge, L'Hospitalet, Spain., Velasco R; Unit of Neuro-Oncology, Department of Neurology, University Hospital of Bellvitge, L'Hospitalet, Spain., Argyriou AA; Division of Clinical Oncology, Department of Medicine, University Hospital of Patras, Patras, Greece., Kalofonos HP; Division of Clinical Oncology, Department of Medicine, University Hospital of Patras, Patras, Greece., Psimaras D; Service de Neurologie Mazarin, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris., Ricard D; Service de Neurologie, Hôpital du Val-de-Grâce, Service de Santé des Armées, Paris, France., Pace A; Neurology Unit, National Cancer Institute Regina Elena, Rome., Galiè E; Neurology Unit, National Cancer Institute Regina Elena, Rome., Briani C; Department of Neurosciences, University of Padova, Padova, Italy., Dalla Torre C; Department of Neurosciences, University of Padova, Padova, Italy., Faber CG; Department of Neurology, Spaarne Hospital, Hoofddorp/Maastricht, University Medical Center, Maastricht., Lalisang RI; Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht., Boogerd W; Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brandsma D; Department of Neuro-oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Koeppen S; Department of Neurology and West German Cancer Center, University of Essen, Essen, Germany., Hense J; Department of Neurology and West German Cancer Center, University of Essen, Essen, Germany., Storey D; Edinburgh Centre for Neuro-Oncology and Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK., Kerrigan S; Edinburgh Centre for Neuro-Oncology and Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK., Schenone A; Department of Neurosciences, Ophthalmology and Genetic, Center of Excellence for Biomedical Research, University of Genova, Genova, Italy., Fabbri S; Department of Neurosciences, Ophthalmology and Genetic, Center of Excellence for Biomedical Research, University of Genova, Genova, Italy., Valsecchi MG; Center of Biostatistics for Clinical Epidemiology, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy., Mazzeo A, Pace A, Pessino A, Schenone A, Toscano A, Argyriou AA, Brouwer B, Frigeni B, Piras B, Briani C, Dalla Torre C, Dominguez Gonzalez C, Faber CG, Tomasello C, Binda D, Brandsma D, Cortinovis D, Psimaras D, Ricard D, Storey D, Cornblath DR, Galiè E, Lindeck Pozza E, Rossi E, Vanhoutte EK, Lanzani F, Pastorelli F, Altavilla G, Cavaletti G, Granata G, Kalofonos HP, Ghignotti I, Merkies ISJ, Bruna J, Hense J, Heimans JJ, Mattavelli L, Padua L, Reni L, Bakkers M, Boogerd M, Campagnolo M, Cazzaniga M, Eurelings M, Leandri M, Lucchetta M, Penas Prado M, Russo M, Valsecchi MG, Piatti ML, Alberti P, Bidoli P, Grant R, Plasmati R, Velasco R, Lalisang RI, Meijer RJ, Fabbri S, Dorsey SG, Galimberti S, Kerrigan S, Koeppen S, Postma TJ, Boogerd W, Grisold W

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2013 Feb; Vol. 24 (2), pp. 454-462. Date of Electronic Publication: 2012 Aug 21.